In today’s high-stakes pharmaceutical environment, patient safety is no longer merely a regulatory checkbox—it is the cornerstone of public trust, clinical responsibility, and operational excellence. As medicinal products enter global…
The Modernization of Cosmetics Regulation Act (MoCRA) 2022 has introduced significant changes to US cosmetics regulations. This new law modernizes…
As the cosmetics industry faces increasing regulatory scrutiny under the Modernization of Cosmetics Regulation Act (MoCRA), brands must adapt quickly…
With Artificial Intelligence (AI) in general, and Generative AI in particular becoming the next big thing in technology, we see…
Narasimha Kumar, Chief Product Officer at Datafoundry, delivered an engaging presentation titled “AI in Drug […]
In the world of safety vigilance, the meticulous task of literature surveillance is crucial for ensuring patient safety and health…
In this Datafoundry Blog, we bring you a timely update regarding the regulation of cosmetics in the US. The US…
Efficiency of case intake is critical to safety vigilance operations. However, the conventional approach of receiving the safety case information…
Safety concerns associated with therapeutic intervention(s) and immunizations can be detected, analyzed, and minimized only through early identification and having…